切换导航
关闭
  • 菜单
  • Setting

BMS 195614

 
Catalog No.
B7459
RARα选择性拮抗剂
组合的产品项目
规格价格库存 数量
1mg
¥ 595.00
Ship with 10-15 days
5mg
¥ 2,437.00
Ship with 10-15 days
10mg
¥ 3,737.00
Ship with 10-15 days
25mg
¥ 10,616.00
Ship with 10-15 days

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

BMS 195614是RARα的选择性拮抗剂[1],可结合RARα亚基[5]。

BMS195614,4-[[[[5,6-二氢-5,5-二甲基-8-(3-喹啉基)]-2-萘基]羰基]氨基]苯甲酸[2],是维甲酸的拮抗剂,通过伴随地转染视黄酸受体(RAR),抑制全反式视黄酸诱导的(ATRA诱导的)视黄酸反应元件-氯霉素乙酰转移酶(RARE-CAT)报告子表达[3][4]。

视黄酸(RA)是维生素A(视黄醇)最主要的具有生物活性的衍生物(一并称作维甲酸)。视黄酸对细胞分化、脊椎动物发育和稳态有多种重要作用[6]。

BMS 195614可逆转RARα选择性激活剂AM580、AM80和BMS 194753对急性早幼粒细胞白血病细胞系NB4和HL60分化的诱导效应[1]。视黄酸(RA)(10-6 M)处理72小时可显著降低T47D乳腺癌细胞转移。但RA与BMS 195614结合不影响细胞运动[7]。在牛肌内脂肪来源的间质-血管细胞中,BMS 195614可显著减弱ATRA的抗脂肪形成作用[8]。

BMS 195614在小鼠口服给药时体内活性较差。BMS 195614口服给药1个月对精子生成无抑制作用[3]。口服BMS 195614不能抑制小鼠精子生成[9]。

参考文献:
[1].  F. Christopher Zusi, Matthew V. Lorenzi and Valerie Vivat-Hannah. Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discovery Today, 2002, 7(23):1165-1174.
[2].  John E. Starrett, Jr., David R. Tortolani, Muzammil M. Mansuri, et al. Bristol-Myers Squibb Co. Retinoid-like Heterocycles. US patent 5,559,248. 1996 Sep. 24.
[3].  Sanny S. W. Chung, Rebecca A. D. Cuellar, Xiangyuan Wang, et al. Pharmacological Activity of Retinoic Acid Receptor Alpha-Selective Antagonists in Vitro and in Vivo. ACS Med. Chem. Lett., 2013, 4: 446-450.
[4].  Eun Young Park, Alice Dillard, Elizabeth A. Williams, et al. Retinol Inhibits the Growth of All-Trans-Retinoic Acid–Sensitive and All-Trans-Retinoic Acid–Resistant Colon Cancer Cells through a Retinoic Acid Receptor–Independent Mechanism. Cancer Res., 2005, 65(21):9923-9934.
[5].  Dongchun Liang, Aijun Zuo, Hui Shao, et al. Retinoic Acid Inhibits CD25 Dendritic Cell Expansion and cd T-Cell Activation in Experimental Autoimmune Uveitis. Invest Ophthalmol Vis Sci., 2013, 54:3493-3503.
[6].  Pierre Chamban. A decade of molecular biology of retinoic acid receptors. FASEBJ., 1996, 10:940-954.
[7].  Flamini Marina Ines, Gauna Gisel Valeria, Sottile Mayra Lis, et al. Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor β. J. Cell. Mol. Med., 2014, 18(6): 1113-1123.
[8].  Nikolas Gunkel, Thorsten Meyer and John Michael Graettinger; N/A. Method of Modulating the Degree of Adipose Tissue Deposited Intramuscularly. US patent 20140094512A1. 2014 Apr. 3.
[9].  Fern E. Murdoch and Erwin Goldberg. Male contraception: Another holy grail. Bioorg. Med. Chem. Lett., 2014, 24:419-424.

化学属性

Physical AppearanceA crystalline solid
StorageStore at -20°C
M.Wt448.5
Cas No.182135-66-6
FormulaC29H24N2O3
SynonymsBMS 614
Solubility<11.21mg/ml in DMSO
Chemical Name4-[[[5,6-dihydro-5,5-dimethyl-8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]-benzoic acid
SDFDownload SDF
Canonical SMILESCC1(CC=C(C2=C1C=CC(C(NC3=CC=C(C(O)=O)C=C3)=O)=C2)C4=CC(C=CC=C5)=C5N=C4)C
运输条件 蓝冰运输或根据您的需求运输。
一般建议不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

质量控制

质量控制和MSDS

批次:

化学结构

BMS 195614